BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33422067)

  • 1. Appraisal of long-time outcomes after curative surgery in elderly patients with gastric cancer: a propensity score matching analysis.
    Matsunaga T; Ishiguro R; Miyauchi W; Shishido Y; Miyatani K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Honjo S; Saito H; Fujiwara Y
    BMC Surg; 2021 Jan; 21(1):33. PubMed ID: 33422067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of laparoscopic spleen-preserving splenic hilar lymphadenectomy on the surgical outcome of proximal gastric cancer: a propensity score-matched, case-control study.
    Huang CM; Chen T; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Mar; 31(3):1383-1392. PubMed ID: 27450211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis After Laparoscopic Gastrectomy in Patients with Pathological Stage II or III Gastric Cancer Who Were Preoperatively Diagnosed with Clinical Stage I: Propensity Score Matching Analysis of a Multicenter Dataset.
    Ito Y; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    Ann Surg Oncol; 2020 Jan; 27(1):268-275. PubMed ID: 31493125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to patient propensity to receive adjuvant chemotherapy and outcomes in stage III gastric cancer cases after D2 surgery.
    Chen JS; Hung CY; Liu KH; Tsai CY; Kuo YC; Hsu JT; Chou WC
    Asian J Surg; 2019 May; 42(5):604-612. PubMed ID: 30249414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative outcomes and survival in elderly patients aged ≥ 75 years undergoing gastrectomy for gastric cancer: an 18-year retrospective analysis in a single Western centre.
    Tan E; Lam S; Han SP; Storey D; Sandroussi C
    Langenbecks Arch Surg; 2021 Jun; 406(4):1057-1069. PubMed ID: 33770264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of laparoscopic surgery compared to open standard surgery for gastric carcinoma in elderly patients: propensity score-matching analysis.
    Yamamoto M; Shimokawa M; Kawano H; Ohta M; Yoshida D; Minami K; Ikebe M; Morita M; Toh Y
    Surg Endosc; 2019 Feb; 33(2):510-519. PubMed ID: 30030615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit of gastrectomy for gastric cancer in patients ≥85 years old: A retrospective propensity score-matched analysis.
    Endo S; Shimizu Y; Ikenaga M; Ohta K; Yamada T
    Surgery; 2017 Apr; 161(4):984-994. PubMed ID: 27894711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic feasibility of D1+ gastrectomy for patients with cT1N1, cT2N0-1, or cT3N0 gastric cancer.
    Kota I; Makoto H; Satoshi K; Yutaka T; Etsuro B; Masanori T
    Eur J Surg Oncol; 2021 Feb; 47(2):456-462. PubMed ID: 32919813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years.
    Liang YX; Deng JY; Guo HH; Ding XW; Wang XN; Wang BG; Zhang L; Liang H
    World J Gastroenterol; 2013 Oct; 19(39):6568-78. PubMed ID: 24151383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.
    Kang JH; Ryu SY; Jung MR; Jeong O
    Eur J Surg Oncol; 2020 Jul; 46(7):1239-1246. PubMed ID: 32331983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset.
    Hayashi S; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    Gastric Cancer; 2019 Jul; 22(4):853-863. PubMed ID: 30483985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
    Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
    BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis.
    Inokuchi M; Nakagawa M; Tanioka T; Okuno K; Gokita K; Kojima K
    Surg Endosc; 2018 Feb; 32(2):735-742. PubMed ID: 28726137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
    Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
    Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 19. Severity of complications and long-term survival after laparoscopic total gastrectomy with D2 lymph node dissection for advanced gastric cancer: A propensity score-matched, case-control study.
    Li Z; Bai B; Zhao Y; Yu D; Lian B; Liu Y; Zhao Q
    Int J Surg; 2018 Jun; 54(Pt A):62-69. PubMed ID: 29698790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is curative gastrectomy justified for gastric cancer with cytology positive as the only stage IV factor?
    Komatsu S; Shioaki Y; Furuke H; Ohta A; Tsuji R; Tanaka S; Kumano T; Imura KI; Shimomura K; Ikeda J; Taniguchi F; Ueshima Y; Lee CJ; Deguchi E; Ikeda E; Otsuji E
    Langenbecks Arch Surg; 2019 Aug; 404(5):599-604. PubMed ID: 31073759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.